Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease
- Resource Type
- Article
- Source
- JTO Clinical and Research Reports; June 2020, Vol. 1 Issue: 2
- Subject
- Language
- ISSN
- 26663643